BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 10556963)

  • 21. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering.
    Keeney M; Chin-Yee I; Weir K; Popma J; Nayar R; Sutherland DR
    Cytometry; 1998 Apr; 34(2):61-70. PubMed ID: 9579602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
    Fruehauf S; Klaus J; Huesing J; Veldwijk MR; Buss EC; Topaly J; Seeger T; Zeller LW; Moehler T; Ho AD; Goldschmidt H
    Bone Marrow Transplant; 2007 Jun; 39(12):743-50. PubMed ID: 17450182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers.
    Sutherland DR; Nayyar R; Acton E; Giftakis A; Dean S; Mosiman VL
    Cytotherapy; 2009; 11(5):595-605. PubMed ID: 19513900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.
    D'Hondt L; André M; Guillaume T; Feyens AM; Humblet Y; Doyen C; Bosly A; Dromelet A; Chatelain B; Symann M
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric experience with autologous peripheral blood progenitor cell transplantation: influence of CD34+ cell dose in engraftment kinetics.
    Diaz MA; Alegre A; Villa M; Granda A; de la Vega A; Ramirez M; Ruano D; Gonzalez A; Merino JM; Madero L
    Bone Marrow Transplant; 1996 Oct; 18(4):699-703. PubMed ID: 8899183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: comparison of a volumetric assay and the ISHAGE gating strategy.
    Leuner S; Arland M; Kahl C; Jentsch-Ullrich K; Franke A; Höffkes HG
    Bone Marrow Transplant; 1998 Oct; 22(7):699-706. PubMed ID: 9818700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM
    Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
    Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
    J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.
    Delamain MT; Metze K; Marques JF; Reis AR; De Souza CA; Lorand-Metze I
    Transfus Apher Sci; 2006 Feb; 34(1):33-40. PubMed ID: 16376618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
    Rowley SD; Loken M; Radich J; Kunkle LA; Mills BJ; Gooley T; Holmberg L; McSweeney P; Beach K; MacLeod B; Appelbaum F; Bensinger WI
    Bone Marrow Transplant; 1998 Jun; 21(12):1253-62. PubMed ID: 9674860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct volumetric flow cytometric quantitation of CD34+ stem and progenitor cells.
    Gutensohn K; Nikolitsis A; Gramatzki M; Spitzer D; Buwitt-Beckmann U; Humpe A
    Transfus Med; 2012 Jun; 22(3):205-10. PubMed ID: 22519551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study.
    Gratama JW; Kraan J; Keeney M; Sutherland DR; Granger V; Barnett D
    Cytotherapy; 2003; 5(1):55-65. PubMed ID: 12745591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simplified method of CD34+ cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment.
    Sandhaus LM; Edinger MG; Tubbs RR; Goormastic M; Baucco PA; Serafino SE; Bolwell BJ
    Exp Hematol; 1998 Jan; 26(1):73-8. PubMed ID: 9430516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
    Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
    Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
    Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ
    Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.